Moreover, a high ATG5 protein level was significantly correlated with the overall survival in CRC patients with AJCC pathological stages I + II (p = 0.006, Figure 3A) and III + IV (p = 0.024), particularly in CRC patients with advanced T stage T3 + T4 (p = 0.001, Figure 3B) and without lymph node invasion N0 (p = 0.001, Figure 3C). Here, ATG5 is linked to colorectal carcinoma.